Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].
Molecular Weight:
666.77
Purity:
99.92
CAS Number:
[356057-34-6]
Formula:
C36H38F4N4O2S
Target:
Apoptosis,Phospholipase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
